TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2023

Enfortumab Vedotin With or Without Pembrolizumab in Cisplatin-Ineligible Patients With Previously Untreated Locally Advanced or Metastatic Urothelial Cancer.

Peter H O'Donnell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.